NASHVILLE, Tenn.--(BUSINESS WIRE)--Pathfinder, a medical device company with first to market products for “surgical GPS” of the abdomen, announced that it has hired Skip Goode as President and CEO effective immediately. As head of Sales for leading edge companies including Medtronic Surgical Navigation, Accuray, and EndoGastric Solutions, Mr. Goode played a pioneering role in key product launches and sales efforts for innovative capital equipment and disposable tools in the surgical oncology field. Mr. Goode takes the helm in advance of the AHPBA conference where Pathfinder will launch its two FDA-cleared products for pre-operative planning and intra-operative navigation of liver surgery.
“We conducted an exhaustive, nationwide search to find the best leader for Pathfinder,” said Clay B. Thorp, General Partner, Hatteras Venture Partners and Chair of the Board and search committee for Pathfinder. “Skip brought the right blend of experience, character, and vision. Having led sales in highly successful companies in our field, we felt he was ready to take his skills to the next level as CEO of Pathfinder.”
“I am thrilled with the opportunity to lead Pathfinder," said Skip Goode, President and CEO of Pathfinder. "The engineering and scientific teams have done a terrific job of designing, building, and gaining FDA clearance for the first system for surgical planning and intra-operative navigation of liver surgery. Now, we have a great opportunity to introduce these systems to hospitals across the country. Pathfinder's ability to increase the number of operable liver cancers and improve the confidence of liver surgeons has the potential to save lives and drive significant economic benefits for health care.”
About Pathfinder Therapeutics, Inc.
Pathfinder Therapeutics, Inc. is a medical device company dedicated to increasing the number and effectiveness of surgeries on abdominal organs or other organs below the chest. Pathfinder improves surgical precision by allowing surgeons to “see through” the organ they are operating on by registering the surgical instrument in three dimensional space onto pre-operative patient medical images. Pathfinder is the first company to receive FDA clearance for a medical device to navigate liver surgery using preoperative medical images. Pathfinder’s intra-operative guidance system uses state-of-the-art line of sight localization and laser range scanning surface registration techniques to show surgeons where they are in the context of their target organ and underlying structures. In addition, Pathfinder sells a software system for pre-operative liver surgery planning. Beyond the liver, Pathfinder is developing future systems for the kidney, pancreas, and other organs. For more information, go to: www.liversurgery.com.
Jim Stefansic, Ph.D., 615-783-0094